Article
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
Annals of surgical oncology - 1 Feb 2009
Chen Jinyun, Li Donghui, Killary Ann M, Sen Subrata, Amos Christopher I, Evans Douglas B, Abbruzzese James L, Frazier Marsha L
Abstract excerpt
Genetic polymorphisms play an important role in clinical response to cytotoxic therapies. We hypothesized that polymorphisms in cell cycle genes may modulate response to preoperative chemoradiation and survival of pancreatic cancer patients. We evaluated 12 single-nucleotide polymorphisms (SNPs) of ten cell cycle genes in 88 patients with resectable adenocarcinoma of the pancreatic head who were treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
